Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1562 of 5804
-
Could a Light-Based blood treatment help Early-Stage skin cancer patients?
Disease control Recruiting nowThe purpose of this study is to determine whether photopheresis therapy can be used to improve the clinical course of early stage cutaneous T-cell lymphoma (CTCL). Currently, photopheresis is performed as a palliative treatment for late stage CTCL. However, recent studies have de…
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New antibiotic cocktail aims to slash infection risk in severe bone breaks
Disease control Recruiting nowThe PRCT evaluates infection outcomes as well as fracture and antibiotic-related complications to include the emergence of resistant bacteria associated with two different antibiotic strategies in the treatment of Gustilo type IIIB tibia and hindfoot fractures (calcaneus and talu…
Phase: PHASE3 • Sponsor: Major Extremity Trauma Research Consortium • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for advanced cancers? JAB-8263 enters human testing
Disease control Recruiting nowThis is a Phase 1/2a, first-in-human, open-label study of JAB-8263, this study has two parts: solid tumor dose escalation and expansion study and hematology tumor dose escalation and expansion study. These two parts will determine the maximum tolerated dose (MTD), recommended Ph…
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Ongoing* To evaluate the safety and tolerability of ERAS-007 monotherapy administered once weekly (QW) and twice daily-once weekly (BID-QW). * To determine the Maximum Tolerated Dose (MTD) and/or Recommended Dose (RD) of ERAS-007 monotherapy administered BID-QW. * To characterize the ph…
Phase: PHASE1, PHASE2 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for moms with hepatitis b: drug may stop baby from getting the virus
Disease control Recruiting nowThe purpose of this study is to evaluate the pharmacokinetics, efficacy and safety of TAF in HBV-infected pregnant women.
Phase: PHASE4 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 26, 2026 15:20 UTC
-
Can early surgery stop brain tumors from returning?
Disease control TerminatedThis clinical trial evaluates the side effects and possible benefits of operating on brain tumors prior to the tumor coming back (recurrence). Understanding when surgery is most useful to patients with brain tumors is important. Some patients may undergo chemotherapy or radiation…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a thyroid hormone boost fertility in PCOS? new trial tests combination therapy
Disease control Recruiting nowThe goal of this randomized controlled trial is to compare letrozole alone versus letrozole plus levothyroxine for ovulation induction in infertile women with both PCOS and subclinical hypothyroidism. The main questions it aims to answer are: Is letrozole plus levothyroxine supe…
Phase: NA • Sponsor: Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy • Aim: Disease control
Last updated Jun 26, 2026 12:45 UTC
-
Heart drug aficamten tested for Long-Term safety in 900 patients
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to collect long-term safety and tolerability data for aficamten.
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug aims to slow Parkinson's progression in early stages
Disease control OngoingThis is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication.
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-2127 in patients with advanced B-cell malignancies.
Phase: PHASE1 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Drug combo aims to boost remission in rare lymphoma
Disease control OngoingThis study will help researchers understand how effective the combination of venetoclax and rituximab is in treating MZL in people who have not received a previous treatment for their cancer.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Which PEEP level saves preemie lungs? major trial seeks answer
Disease control OngoingPremature babies often need help immediately after birth to open their lungs to air, start breathing and keep their hearts beating. Opening their lungs can be difficult, and once open the under-developed lungs of premature babies will often collapse again between each breath. To …
Phase: NA • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug targets rare sarcomas and GIST with genetic mutations
Disease control OngoingThis phase II trial studies the effect of rogaratinib in treating patients with sarcoma with a change in a group of proteins called fibroblast growth factor receptors (FGFRs) or SDH-deficient gastrointestinal stromal tumor (GIST). Rogaratinib may stop the growth of tumor cells by…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Glowing dye could cut bowel leak risk in ovarian cancer surgery
Disease control Recruiting nowThe purpose of this study is to find out whether using the PINPOINT imaging system intra-operatively can reduce the risk of anastomotic leaks and other complications after surgery for ovarian cancer, compared with standard intra-operative assessments alone. The PINPOINT endoscopi…
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Which blood product works best in the field for major bleeding?
Disease control CompletedThe aim of study is to compare clinical and biochemical effect of three different transfusion strategies among patients with major hemorrhage requiring prehospital transfusion. A) Present prehospital standard treatment including a mixture of plasma and Red blood cell transfusion…
Phase: NA • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New prostate cancer drug shows promise in early trial
Disease control OngoingThis is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate cancer (mPC).
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can family coaching help teens beat obesity? new study tests Home-Based program
Disease control OngoingObesity is one of the most prevalent medical problems facing children and adolescents today, particularly among African American adolescents where the rate is alarmingly high. This study will test the effectiveness of FIT Families, a multicomponent family-based behavioral interve…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New study aims to cut back pain and unnecessary care for troops and veterans
Symptom relief OngoingThe RESOLVE trial will provide a pragmatic approach to evaluate whether Physical Therapy Clinical Practice Guideline adherence can reduce pain, disability and downstream healthcare utilization for low back pain within the Departments of Defense and Veterans Affairs healthcare sys…
Phase: NA • Sponsor: Sara Gorczynski • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can air filters stop surgical infections? huge trial aims to find out
Prevention OngoingDetermine whether operating room air filtration and sterilization with the ActivePure system reduces a composite of serious surgical site infections, infection-related complications, and death within 30 days after surgery.
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Can intense exercise heal your heart after a heart attack?
Disease control CompletedThis study will investigate the effect of a 12-weeks cardiac rehabilitation training (HIIT, MICT) program on VO2peak and cardiac fibrosis in patients, and evaluate the effects of HIIT on endothelial function, microvascular obstruction, body fat, inflammation, arrhythmia and psych…
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC